Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Mathematical Model Offers Smarter Way To Understand How Information Travels In Cells

27.03.2008
Method allows scientists to tap today’s computing power to better analyze cellular signaling pathways key in cancer and other diseases

Looking for answers in the bright light of day, rather than the confined beam of a street light at night. That’s how University of Michigan researcher Sofia Merajver, M.D., Ph.D., describes the power of a new mathematical model that could have far-reaching impact on how scientists study cellular signaling pathways.

“This has the potential to be a true paradigm shift,” says Merajver, a professor in the U-M Department of Internal Medicine and co-director of the Breast Oncology Program at the U-M Comprehensive Cancer Center. She is the senior author of a study about the new model published online March 21 in the open-access journal PLoS Computational Biology.

Around the world, researchers scrutinize the pathways inside cells where signals travel and activate or suppress thousands of cell functions. The researchers want to learn which cellular processes are key in causing disease conditions and how to target them with new drugs. Understanding the full complexity of signaling pathways and their interactions is critical in discovering effective treatments for cancer, inflammation and other conditions that affect millions of people.

... more about:
»Merajver »Researcher »Signaling »Target »pathway

The full description of the new model in the article immediately offers scientists the opportunity to improve current mathematical models with a superior tool that can take advantage of advances in computing power, says Merajver.

“I would hope that it may help guide us much better than our own intuition to decide what our targets are,” she says. “If we can understand these pathways better, we should be able to pick more effective targets. This is the step before screening a drug. Until now, there have been very few tools to help us choose a target.”

New model enables complex analysis
Merajver’s collaborators in the study are first author Alejandra C. Ventura, Ph.D., a post-doctoral fellow in the U-M Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center; and Jacques-A. Sepulchre, a mathematical physicist at the Institut Non Lineaire de Nice at the Universite de Nice Sophia-Antipolis in Valbonne, France.

The authors developed the model and tested it using experimental data from a well-known signaling pathway involved in many disease states, the MAPK pathway. They found that this kind of signaling pathway naturally transmits information not just in a forward direction, but also backwards. That implies new considerations if drugs are to adequately address key targets.

In addition, the study will enable scientists to construct models that take into account interactions between two pathways, or “cross-talk,” Merajver says.

A specialist in inflammatory breast cancer, Merajver previously has discovered oncogenes that foster metastasis. Her lab has numerous plans to put the model to work immediately.

“We hope it will broaden our understanding on how to inhibit metastasis, since our lab studies this aspect of cancer; this work has many applications for normal and disease conditions,” she says.

Citation: http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1000041

Funding for the study came from the Breast Cancer Research Foundation, the U.S. Department of Defense Breast Cancer Research Program, The Burroughs Wellcome Fund and the National Institutes of Health.

Andrew Hyde | alfa
Further information:
http://www.ploscompbiol.org

Further reports about: Merajver Researcher Signaling Target pathway

More articles from Life Sciences:

nachricht MicroRNA helps cancer evade immune system
19.09.2017 | Salk Institute

nachricht Ruby: Jacobs University scientists are collaborating in the development of a new type of chocolate
18.09.2017 | Jacobs University Bremen gGmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>